SG Sides With Teva In High Court Skinny Label Patent Case
The U.S. solicitor general said Wednesday that the U.S. Supreme Court should grant Teva's request for review of a Federal Circuit decision on so-called skinny labels for pharmaceuticals, saying the appellate...To view the full article, register now.
Already a subscriber? Click here to view full article